Immunization, Hib3 in Small states
Small states: Immunization, Hib3 was 86.6% in 2024. ◆ Volatile
Immunization, Hib3 in Small states, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Small states is 86.6%, measured in 2024.
That represents a change of up 0.3% on the previous year and down 3.0% over ten years.
Over the whole period, immunization, hib3 in Small states peaked at 90.1% in 2013 and was at its lowest, 0.0%, in 1990.
That places Small states 14th out of 43 groups with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Small states, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 1.5% | — |
| 1992 | 1.4% | -5.4% |
| 1993 | 1.4% | -0.2% |
| 1994 | 1.5% | +2.6% |
| 1995 | 1.5% | +0.2% |
| 1996 | 2.0% | +38.6% |
| 1997 | 8.9% | +337.3% |
| 1998 | 9.9% | +11.4% |
| 1999 | 14.4% | +46.3% |
| 2000 | 18.4% | +27.1% |
| 2001 | 27.7% | +51.0% |
| 2002 | 26.3% | -5.2% |
| 2003 | 29.8% | +13.1% |
| 2004 | 31.2% | +4.8% |
| 2005 | 35.6% | +14.1% |
| 2006 | 44.6% | +25.4% |
| 2007 | 47.0% | +5.3% |
| 2008 | 56.9% | +21.0% |
| 2009 | 68.4% | +20.2% |
| 2010 | 72.6% | +6.1% |
| 2011 | 77.6% | +7.0% |
| 2012 | 81.4% | +4.8% |
| 2013 | 90.1% | +10.8% |
| 2014 | 89.2% | -1.0% |
| 2015 | 89.1% | -0.2% |
| 2016 | 88.4% | -0.8% |
| 2017 | 87.6% | -0.9% |
| 2018 | 89.2% | +1.9% |
| 2019 | 90.0% | +0.9% |
| 2020 | 86.7% | -3.7% |
| 2021 | 84.6% | -2.4% |
| 2022 | 86.9% | +2.6% |
| 2023 | 86.4% | -0.6% |
| 2024 | 86.6% | +0.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 4.2% | 0.0% | 14.4% | 10 |
| 2000s | 38.6% | 18.4% | 68.4% | 10 |
| 2010s | 85.5% | 72.6% | 90.1% | 10 |
| 2020s | 86.2% | 84.6% | 86.9% | 5 |
More health data for Small states
- Population ages 35-39, male, annual growth rate 1.16 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 2.29 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0336 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.91 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0397 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, annual growth rate -0.7832 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Small states?
- Immunization, hib3 in Small states was 86.6% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Small states?
- The highest recorded value was 90.1% in 2013.
- What is the lowest immunization, hib3 recorded in Small states?
- The lowest recorded value was 0.0% in 1990.
- How does Small states rank for immunization, hib3?
- Small states ranks 14th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Small states?
- Over the last ten years it is down 3.0%. The long-run trend across the full record is volatile.
- Where does this Small states data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.